Longevity · Longevity peptide (research)
5-Amino-1MQ
- Drug class
- Longevity peptide (research)
- Status
- Compounded (503A)
- Also known as
- 5 amino 1mq, 5amino1mq, amino-1mq, 1-methylquinolinium, nnmt inhibitor
- Reviewed
- 2026-06-01 · Dr. Ana Lisa Carr, MD
What 5-Amino-1MQ is studied for
- NNMT inhibition (research)
- Fat metabolism (research)
- Muscle preservation (research)
Mechanism of action
5-Amino-1MQ is being studied in the longevity category. NNMT inhibitor studied for fat loss, muscle preservation, and NAD+ support. Mechanism of action varies by study model; refer to the kindr clinical library for a deeper writeup.
Frequently asked questions
What is 5-Amino-1MQ?
5-Amino-1MQ is a longevity peptide. NNMT inhibitor studied for fat loss, muscle preservation, and NAD+ support.
What is 5-Amino-1MQ studied for?
Published research has examined 5-Amino-1MQ for nnmt inhibition, fat metabolism, muscle preservation. Human clinical evidence varies by indication.
Is 5-Amino-1MQ FDA-approved?
No. 5-Amino-1MQ is not FDA-approved for the indications listed. It is available compounded by 503A pharmacies under clinician supervision, or for international research use only on this catalog.
How is 5-Amino-1MQ used in research?
Protocols vary by study. 5-Amino-1MQ is typically administered subcutaneously in research settings. No validated human therapeutic dose exists outside FDA-approved indications.
What are the known risks?
Long-term human safety data for 5-Amino-1MQ is limited. Theoretical risks vary by mechanism. Any human use should be supervised by a licensed clinician.